First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.

[1]  K. Tabynov.  Influenza viral vector based Brucella abortus vaccine: a novel vaccine candidate for veterinary practice , 2016, Expert review of vaccines.

[2]  K. Tabynov,et al.  Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection. , 2016, Vaccine.

[3]  K. Tabynov,et al.  Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers , 2015 .

[4]  K. Tabynov,et al.  An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers. , 2015, Vaccine.

[5]  K. Tabynov,et al.  Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers. , 2014, Vaccine.

[6]  K. Tabynov,et al.  Safety of the novel vector vaccine against Brucella abortus based on recombinant influenza viruses expressing Brucella L7/L12 and OMP16 proteins, in cattle , 2014 .

[7]  K. Tabynov,et al.  Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection. , 2014, Vaccine.

[8]  B. Ferko,et al.  Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection , 2014, Virology Journal.

[9]  K. Tabynov,et al.  Immunogenic and protective properties of the first kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in Ferrets , 2012, Virologica Sinica.

[10]  G. Ferguson,et al.  Importance of Lipopolysaccharide and Cyclic β-1,2-Glucans in Brucella-Mammalian Infections , 2010, International journal of microbiology.

[11]  Fatemeh Shakeri,et al.  Spa Diversity among MRSA and MSSA Strains of Staphylococcus aureus in North of Iran , 2010, International journal of microbiology.

[12]  L. Reperant,et al.  Avian influenza viruses in mammals. , 2009, Revue scientifique et technique.

[13]  Marcel Tanner,et al.  Human Benefits of Animal Interventions for Zoonosis Control , 2007, Emerging infectious diseases.

[14]  H. Katinger,et al.  Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against Tuberculosis Challenge , 2006, Clinical and Vaccine Immunology.

[15]  M. Durán-Ferrer,et al.  Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis. , 2004, Veterinary microbiology.

[16]  Nammalwar Sriranganathan,et al.  Brucellosis vaccines: past, present and future. , 2002, Veterinary microbiology.

[17]  A. Benkirane,et al.  Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. , 2001, Revue scientifique et technique.

[18]  Z. Bercovich.  The use of skin delayed‐type hypersensitivity as an adjunct test to diagnose brucellosis in cattle: A review , 2000, The Veterinary quarterly.

[19]  B. Garin‐Bastuji,et al.  Brucella melitensis infection in sheep: present and future. , 1998, Veterinary research.

[20]  M. J. Corbel,et al.  Brucellosis: an overview. , 1997, Emerging infectious diseases.

[21]  G. Splitter,et al.  CD8+ Type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I‐ and class II‐deficient mice , 1995, European journal of immunology.

[22]  X. Jiang,et al.  Effects of cytokines on intracellular growth of Brucella abortus , 1993, Infection and immunity.

[23]  Lopez Jw,et al.  Influenza virus in ruminants: a review. , 1984 .